Literature DB >> 20168263

Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children.

Corinne Levy1, Muhamed-Kheir Taha, Catherine Weil Olivier, Beatrice Quinet, Aurélie Lecuyer, Jean Michel Alonso, Yannick Aujard, Edouard Bingen, Robert Cohen.   

Abstract

BACKGROUND: Neisseria meningitidis meningitis represents approximately one-half of the meningococcal cases in French children. To explore the contribution of bacterial typing in improving the management of cases, we aimed to describe clinical characteristics and mortality of meningococcal meningitis in children reported to the multicenter survey system, GPIP/ACTIV, in association with phenotypes/genotypes of bacterial isolates.
METHODS: From 2001 to 2005, 259 pediatric wards and 168 microbiology laboratories enrolled all children with bacterial meningitis. Risk factors, vaccination status, signs and symptoms, cerebrospinal fluid analysis, treatments and case fatality rate were recorded.
RESULTS: A total of 962 cases of Neisseria meningitidis meningitis among a total of 2131 bacterial meningitis (45%) were recorded (mean age, 4.5 +/- 4.7 years). Serogroup distribution of the isolates was 62.3%, 33.7%, 2.9%, 0.6%, and 0.6% for serogroups B, C, W135, A and Y, respectively. The major clonal complexes were ST-41/44 (32.2%), ST-11 (21.9%), ST-32 (20.8%), ST-8 (8.2%), and ST-269 (4.9%). Despite global heterogeneity of the isolates, 2 phenotypes/genotypes were of interest. Isolates of the phenotype/genotype B:14:P1.7,16/ST-32 (56% clustered in the region of Haute Normandie) were observed in older children (8.6 years) and were associated with a higher case fatality rate (12%) than were other phenotypes of serogroup B. The phenotype/genotype C:2a:P1.5/ST-11 was found in 26.3% of serogroup C cases and was possibly associated with a higher mortality among serogroup C (9.9% for C and 5.9% for B, P = 0.04).
CONCLUSIONS: This large survey provides data that could be important for implementation of future vaccines. Typing of meningococcal isolates could contribute to an understanding of prognosis in meningococcal meningitis.

Entities:  

Mesh:

Year:  2010        PMID: 20168263     DOI: 10.1097/INF.0b013e3181d3ce32

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

Review 1.  The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology.

Authors:  Vanessa N Racloz; Silva J D Luiz
Journal:  BMC Infect Dis       Date:  2010-06-17       Impact factor: 3.090

Review 2.  Meningococcal vaccination in pregnancy.

Authors:  Bahaa Abu Raya; Manish Sadarangani
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

3.  Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease.

Authors:  Michael Bröker; Brian Cooper; Lisa M Detora; Jeffrey J Stoddard
Journal:  Infect Drug Resist       Date:  2011-07-22       Impact factor: 4.003

4.  Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections.

Authors:  Magnus Gottfredsson; Ingi K Reynisson; Ragnar F Ingvarsson; Hafrun Kristjansdottir; Martina V Nardini; Jon F Sigurdsson; Rachel Schneerson; John B Robbins; Mark A Miller
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

5.  Meningococcal disease serogroup C.

Authors:  Félix O Dickinson; Antonio E Pérez; Iván E Cuevas
Journal:  Risk Manag Healthc Policy       Date:  2012-03-08

6.  The health, social and educational needs of children who have survived meningitis and septicaemia: the parents' perspective.

Authors:  Laura J Clark; Linda Glennie; Suzanne Audrey; Matthew Hickman; Caroline L Trotter
Journal:  BMC Public Health       Date:  2013-10-10       Impact factor: 3.295

7.  Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia.

Authors:  Shakeel Mowlaboccus; Timothy T Perkins; Helen Smith; Theo Sloots; Sarah Tozer; Lydia-Jessica Prempeh; Chin Yen Tay; Fanny Peters; David Speers; Anthony D Keil; Charlene M Kahler
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.